Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call reflects a mixed sentiment. While the company is optimistic about HRScale's potential and profit recovery, there are challenges like lowered guidance and competitive pricing pressures. The Q&A reveals cautious optimism, with no significant negative surprises but also no strong positive catalysts. The market cap suggests moderate stock volatility. Given the mixed financial performance and guidance, the stock price is expected to remain relatively stable over the next two weeks, resulting in a neutral sentiment rating.
Adjusted EPS $1.31, a 17% decrease year-over-year from $1.57. The decrease was due to a higher effective tax rate (41% in Q1 2026 vs. 29% in Q1 2025) caused by a lower stock price reducing tax benefits from stock compensation vesting.
Adjusted EBITDA $103 million, a 1% increase year-over-year from $102 million. This was driven by outperformance in gross profit and operating expense management, partially offset by slightly lower-than-expected unit growth.
Average Paid Worksite Employees 303,049, a 1% decrease year-over-year. The decline was attributed to lower new client sales (down 7% year-over-year) and client attrition (11%, within the historical range of 9%-12%).
Total Gross Profit $302 million, a 3% decrease year-over-year. This was an improvement compared to the 21% decline in Q4 2025, driven by lower-than-expected benefit costs but offset by lower worksite employee volume.
Gross Profit Per Worksite Employee $332 per month, slightly above forecast. The increase was due to lower-than-expected benefit costs.
Benefit Cost Per Covered Employee Increased by 5% year-over-year, an improvement compared to the 9% increase in 2025. This was driven by favorable client mix changes, plan design changes, and new contract terms with UnitedHealthcare.
Total Operating Expenses $240 million, a 1% decrease year-over-year. Excluding a $9 million restructuring charge, operating expenses decreased by 5%, driven by workforce realignment and cost management.
HRScale Investment $13 million in Q1 2026, consistent with Q1 2025. However, $8 million was in operating expenses and $5 million in capitalized costs, compared to all expenses in Q1 2025.
Effective Income Tax Rate 41% in Q1 2026, up from 29% in Q1 2025. The increase was due to a lower stock price reducing tax benefits from stock compensation vesting.
Dividends Paid $23 million in Q1 2026, consistent with the company's regular dividend program.
Stock Repurchase 171,000 shares repurchased at a cost of $4 million in Q1 2026.
Adjusted Cash $36 million as of March 31, 2026, a decrease due to seasonal working capital fluctuations, including timing of corporate payroll, healthcare, and software maintenance contract funding.
HRScale rollout: Initial HRScale beta clients were onboarded in March, with payrolls and invoices processed in April. The pipeline for HRScale clients is building, with commitments for nearly 6,000 worksite employees to be onboarded within the next 6 months. HRScale combines Insperity's HR services with Workday technology, targeting mid-market businesses with 150 to 5,000 employees.
AI-driven business formation: AI is driving new business formation in the U.S., with applications reaching nearly 500,000 a month in Q1 2026, especially in AI-focused sectors. Growth remained strong at about 12% year-over-year for Q1.
Margin recovery plan: Progress made in Q1 2026 with a 3% decrease in gross profit compared to Q1 2025, a significant improvement from the 21% decline in Q4 2025. Strategies include a new agreement with UnitedHealthcare, benefit plan design changes, strategic pricing, and client selection.
Operating expense management: Total operating expenses decreased by 1% to $240 million in Q1 2026, including a $9 million restructuring charge. Excluding this charge, operating expenses decreased by 5%.
AI initiatives: AI is being integrated into Insperity's HR services, including proprietary AI agents for HR360 clients. These agents aim to improve client engagement, streamline operations, and enhance decision-making through real-time insights.
Worksite Employee Growth: The average number of paid worksite employees decreased by 1.0% compared to Q1 2025, with new client sales declining by 7% and client attrition at 11%, which is at the higher end of the historical range. This decline impacts revenue and growth momentum.
Client Retention and Sales: Lower-than-expected booked sales and client retention were attributed to the margin recovery plan, which affected pricing and client selection. Persistent attrition at the higher end of historical levels is expected to continue, impacting profitability and growth.
Macroeconomic Challenges: Macroeconomic factors, including inflation fears, international conflicts, and tariff uncertainties, are causing small- and medium-sized businesses to become more cautious, potentially affecting hiring and expansion.
Benefit Costs: Benefit costs per covered employee increased by 5% over Q1 2025, though this is an improvement from the previous year. However, the new pooling level with UnitedHealthcare introduces higher fixed premiums, which could impact financials.
Operating Expenses: A $9 million restructuring charge related to severance costs and workforce realignment was incurred. While operating expenses decreased overall, these restructuring costs highlight challenges in managing operational efficiency.
Small Business Sentiment: A decline in optimism among small- and medium-sized businesses was noted, with 54% expecting negative economic impacts. This sentiment could lead to reduced hiring and slower business growth.
AI and Workforce Disruption: AI-driven transformations may lead to workforce disruptions, particularly in white-collar and entry-level roles, potentially affecting employment growth and creating volatility in the SMB sector.
Margin Recovery Plan: The company is focusing on margin recovery as the first priority in its 3-year plan. Strategies include a new agreement with UnitedHealthcare, benefit plan design changes, strategic pricing, and client selection. The goal is to achieve a full recovery by 2027.
HRScale Rollout: HRScale, a new comprehensive HR solution, has been launched. It combines Insperity's HR services with Workday technology, targeting mid-market businesses with 150 to 5,000 employees. Initial beta clients were onboarded in March, and the pipeline is building with commitments for nearly 6,000 worksite employees within the next 6 months.
AI Initiatives: The company is leveraging AI to enhance HR services, streamline operations, and accelerate product development. AI agents are being integrated into HR360 to improve client and employee experiences, provide real-time insights, and boost productivity.
Worksite Employee Growth: The company revised its worksite employee growth forecast for 2026 to a range of 303,000 to 307,000, representing a decrease of 1% to 2.3% from 2025. Q2 2026 is expected to have 302,500 to 304,500 paid worksite employees, a decline of 1.5% to 2.1% from Q2 2025.
Adjusted EBITDA Guidance: The company maintains its adjusted EBITDA guidance for 2026 in the range of $170 million to $230 million, despite lower worksite employee volume, due to progress in margin recovery.
Adjusted EPS Guidance: The adjusted EPS guidance for 2026 has been revised to a range of $1.60 to $2.60, reflecting changes in the effective tax rate and outstanding shares.
Operating Expenses: Operating expenses are expected to decrease year-over-year in 2026, driven by lower headcount and HRScale expenses, partially offset by increased marketing spend and inflationary cost increases.
Tax Rate and Shares: The effective tax rate for adjusted EPS purposes is expected to be 36% for 2026, with weighted average outstanding shares at approximately 38.5 million for the remainder of the year.
Dividend Payments: During the first quarter, the company paid $23 million in dividends as part of its regular dividend program.
Share Repurchase: The company repurchased 171,000 shares of stock at a cost of $4 million during the first quarter.
The earnings call reflects a mixed sentiment. While the company is optimistic about HRScale's potential and profit recovery, there are challenges like lowered guidance and competitive pricing pressures. The Q&A reveals cautious optimism, with no significant negative surprises but also no strong positive catalysts. The market cap suggests moderate stock volatility. Given the mixed financial performance and guidance, the stock price is expected to remain relatively stable over the next two weeks, resulting in a neutral sentiment rating.
The earnings call summary presents a mixed outlook. While there are positive elements like the HRScale rollout and strategic partnerships, concerns about elevated benefits costs, uncertain client transitions, and a lack of specific guidance on profitability metrics temper enthusiasm. The Q&A section highlights management's reluctance to provide specific details, adding to uncertainty. Given the company's mid-cap size, these factors suggest a neutral stock price reaction in the short term.
The earnings call revealed disappointing financial results with an EPS miss and lower EBITDA due to high benefits costs. Despite a positive outlook for 2026, the immediate financials are concerning. The Q&A highlighted management's optimism about future recovery and strong sales, but did not address current issues effectively. With a market cap of ~$3.4 billion, the negative financial results and uncertainty in guidance are likely to lead to a negative stock price movement in the short term.
The earnings call presents a mixed picture: strong client retention and efficient sales are positive, but reduced growth guidance and declining gross profit per employee are concerns. The Q&A reveals optimism about future growth and strategic initiatives, yet lacks concrete guidance on the Workday partnership's financial impact. The partnership with Workday and share repurchases provide some optimism, but increased healthcare costs and uncertain future projections temper enthusiasm. Given the market cap of $3.44 billion, the stock price is likely to remain stable, resulting in a neutral prediction.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.